Found 6 results
Author Title [ Type(Desc)] Year
Filters: Author is Thompson, DJ  [Clear All Filters]
Journal Article
S. W. Rabkin, Cheng, X. J., and Thompson, D. J., Detailed Analysis of the Impact of Age on the QT Interval, J Geriatr Cardiol, vol. 13, no. 9, pp. 740-748, 2016.
K. K. Badani, Thompson, D. J., Brown, G., Holmes, D., Kella, N., Albala, D., Singh, A., Buerki, C., Davicioni, E., and Hornberger, J., Effect of a Genomic Classifier Test on Clinical Practice Decisions for Patients with High-Risk Prostate Cancer After Surgery, BJU Int, 2014.
P. L. Nguyen, Shin, H., Yousefi, K., Thompson, D. J., Hornberger, J., Hyatt, A. S., Badani, K. K., Morgan, T., and Feng, F. Y., Impact of a Genomic Classifier of Metastatic Risk on Post Prostatectomy Treatment Recommendations by Radiation Oncologists and Urologists, International Journal of Radiation Oncology • Biology • Physics, vol. 90, p. S442, 2014.
M. Lau, Campbell, H., Tang, T., Thompson, D. J., and Elliott, T., Impact of Patient Use of an Online Patient Portal on Diabetes Outcomes, Can J Diabetes, vol. 38, pp. 17-21, 2014.
R. B. Nussenblatt, Rao, N. A., Foster, C. S., Sen, H. N., Srivastava, S., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Robinson, R. R., Shames, R. S., and Buggage, R. R., Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis, 2003.
R. B. Nussenblatt, Rao, N., Foster, C. S., Sen, H. N., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Shames, R. S., and Buggage, R. R., Uveitis therapy: a phase II study using subcutaneously administered daclizumab, 2004.